Prestige Consumer Healthcare Inc. — Form 10-Q Summary
Reporting period: Quarter and nine months ended December 31, 2019 (fiscal 2020). Amounts below are in U.S. dollars; financial statement amounts are in millions unless stated otherwise.
Business context and results
Prestige develops, markets and distributes over-the-counter healthcare products in North America and international markets. Its reportable segments are North American OTC Healthcare and International OTC Healthcare. The Household Cleaning business was sold in July 2018, affecting year-over-year comparisons.
| Metric | Quarter ended Dec. 31, 2019 | Quarter ended Dec. 31, 2018 | Nine months ended Dec. 31, 2019 | Nine months ended Dec. 31, 2018 |
|---|---|---|---|---|
| Total revenue | $241.6 | $241.4 | $711.8 | $734.8 |
| Gross profit | $137.5 | $139.2 | $408.3 | $417.3 |
| Gross margin | 56.9% | 57.7% | 57.4% | 56.8% |
| Operating income | $76.4 | $77.5 | $217.2 | $221.0 |
| Net income | $38.1 | $38.2 | $105.2 | $103.5 |
| Diluted EPS | $0.75 | $0.73 | $2.05 | $1.97 |
Financial position and cash flow
- Cash and liquidity: Cash was $28.6 million at December 31, 2019. Current assets were $300.4 million and current liabilities $149.0 million. The revolving credit facility had no borrowings and $153.3 million of available capacity.
- Debt: Gross debt was $1.717 billion ($1.701 billion net of unamortized debt costs); cash-adjusted debt was approximately $1.688 billion. Debt comprised $717 million of term loans and $1.0 billion of senior notes. The company reported covenant compliance at quarter-end.
- Cash flow, nine months: Operating activities provided $161.0 million, versus $138.4 million in the prior-year period. Capital expenditures were $9.1 million. Financing activities used $152.0 million; cash increased $1.1 million to $28.6 million.
- Interest: Nine-month interest expense was $74.1 million, down from $79.5 million; interest paid was $66.3 million.
Material changes versus prior comparable periods
- Quarterly revenue was nearly flat (+0.1%). North American OTC revenue declined 0.9%, while International OTC revenue grew 8.2%. Management attributed the North American decline mainly to retailer inventory reductions; international growth reflected consumption and geographic expansion, partly offset by currency effects.
- Nine-month revenue fell 3.1%, primarily because the prior-year period included $19.8 million of Household Cleaning sales before its divestiture. Excluding that segment, OTC revenue declined 0.4%; North American OTC revenue fell 1.2% and International OTC revenue rose 7.1%.
- Quarterly gross margin fell to 56.9%, mainly due to costs associated with changing warehouse locations. For nine months, gross margin rose to 57.4%, reflecting the removal of the lower-margin Household Cleaning business, partly offset by warehouse transition costs.
- Nine-month net income increased 1.7% and diluted EPS rose to $2.05 from $1.97. Lower interest expense and income taxes contributed; the quarter also included a $2.2 million debt-extinguishment loss.
- In December 2019, the company issued $400 million of 5.125% notes due 2028 and redeemed $400 million of 5.375% notes due 2021, using proceeds and cash on hand. It recorded a $2.2 million write-off of related debt costs. The revolving facility was amended, including an extension of maturity to five years from the amendment date.
Outlook, risks and unusual items
- Management gave no specific earnings or revenue guidance. It said operating cash generation and existing credit facilities should be sufficient for working capital and capital expenditures over the next 12 months, excluding acquisitions, and anticipated covenant compliance through the remainder of fiscal 2020.
- In January 2020, the company entered into interest-rate swaps covering $400 million of variable-rate debt. At quarter-end, variable-rate debt was approximately $717 million; a 1% rate increase was estimated to adversely affect pre-tax earnings and cash flows by about $5.9 million for the nine-month period.
- Key risks include retailer and customer concentration (Walmart represented 23.4% of nine-month gross revenue), retailer inventory changes, reliance on third-party manufacturers and logistics providers, and the ongoing distribution-center transition. Management warned that disruption could increase costs or impair timely product delivery.
- Goodwill and intangible assets totaled approximately $3.07 billion, a substantial portion of total assets. No impairment indicators were reported at December 31, 2019, but adverse sales, margin, competition, consumer-preference or discount-rate changes could lead to future impairment.
- The company adopted lease accounting Topic 842 on April 1, 2019; prior periods were not restated. It recorded operating and finance lease right-of-use assets and liabilities. Routine legal matters were not expected to have a material adverse effect; the filing disclosed no material change to reported risk factors.
Important facts for investors to verify
- Whether North American sales stabilize as retailer inventory reductions and warehouse-transition costs unwind.
- Whether international growth persists and how currency movements affect reported results.
- Debt reduction, interest-rate exposure, covenant headroom and terms of the new notes, swaps and amended revolving facility.
- Execution and cost effects of the logistics-provider transition, given reliance on third-party distribution and manufacturing.
- Customer concentration, impairment sensitivity of goodwill and intangibles, and the extent to which reported comparisons are affected by the Household Cleaning divestiture.